Meeshanthini V. Dogan
2023
In 2023, Meeshanthini V. Dogan earned a total compensation of $648.9K as CEO at Cardio Diagnostics Holdings, a 86% decrease compared to previous year.
Compensation breakdown
| Option Awards | $341,640 |
|---|---|
| Salary | $300,000 |
| Other | $7,253 |
| Total | $648,893 |
Dogan received $341.6K in option awards, accounting for 53% of the total pay in 2023.
Dogan also received $300K in salary and $7.3K in other compensation.
Rankings
In 2023, Meeshanthini V. Dogan's compensation ranked 1,608th out of 2,659 executives tracked by ExecPay. In other words, Dogan earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,608 out of 2,659 | 40th |
Division Manufacturing | 943 out of 1,457 | 35th |
Major group Chemicals And Allied Products | 595 out of 820 | 27th |
Industry group Drugs | 579 out of 786 | 26th |
Industry In Vitro and In Vivo Diagnostic Substances | 2 out of 10 | 80th |
Source: SEC filing on October 4, 2024.
Dogan's colleagues
We found two more compensation records of executives who worked with Meeshanthini V. Dogan at Cardio Diagnostics Holdings in 2023.